In Brief
Caps trade margins at 30% for 137 anti-cancer drugs, reducing retail prices by up to 70% from November 9.
Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has notified 137 non-scheduled anti-cancer drugs to address excessive trade margins. The government has capped trade margins for these formulations at 30%.
As a direct result of this regulatory price intervention, prices of these 137 cancer medications are set to decrease by up to 70%, with the revised price regime taking effect from November 9.
Railways to turn off train charging points at night to stop fires
29 Oct 2026
Indian Railways Extends 45-Paise Travel Insurance to Counter Tickets
26 Oct 2026
Digital Agriculture Push: 11 Crore Farmers Issued Unique Identification IDs
25 Oct 2026
Kerala Sanctions ₹1,081 Crore for Social Security and Welfare Board Pensions
25 Oct 2026